デフォルト表紙
市場調査レポート
商品コード
1543907

腫瘍切除技術の世界市場

Tumor Ablation Technologies


出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
腫瘍切除技術の世界市場
出版日: 2024年08月29日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腫瘍切除技術の世界市場は2030年までに38億米ドルに達する見込み

2023年に16億米ドルと推定される腫瘍切除技術の世界市場は、分析期間2023-2030年にCAGR 13.3%で成長し、2030年には38億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである高周波アブレーションは、CAGR13.7%を記録し、分析期間終了までに14億米ドルに達すると予測されます。マイクロ波アブレーションセグメントの成長は、分析期間中CAGR 14.4%と推定されます。

米国市場は4億2,960万米ドルと推定され、中国はCAGR 12.3%で成長すると予測されます。

米国の腫瘍切除技術市場は、2023年に4億2,960万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGR12.3%で推移し、2030年には5億7,420万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.0%と11.0%と予測されています。欧州では、ドイツがCAGR約9.5%で成長すると予測されています。

世界の腫瘍切除技術市場- 主要動向と促進要因まとめ

腫瘍切除技術とは何か、なぜ重要なのか?

腫瘍切除技術とは、極端な熱や冷たさ、電気エネルギー、または化学薬剤を適用することにより、がん組織を破壊するために使用される低侵襲処置のことです。これらの技術には、ラジオ波焼灼術(RFA)、マイクロ波焼灼術、冷凍焼灼術、化学的焼灼術が含まれます。腫瘍焼灼術は、肝臓、腎臓、肺、骨などの臓器に限局した腫瘍を治療するために極めて重要であり、従来の外科的方法に代わる治療法です。これらの技術は、回復時間の短縮、最小限の侵襲性、腫瘍を正確に標的にする能力など、大きな利点を提供します。腫瘍切除術は、手術の適応とならない患者や、到達困難な場所に腫瘍がある患者にとって特に価値があります。

技術の進歩はどのように市場を形成してきたか?

技術の進歩は腫瘍切除技術の開発と応用に大きな影響を与えてきました。超音波、CT、MRIなどの画像診断技術の革新は、切除処置の精度とガイダンスを向上させ、腫瘍のより正確なターゲティングを可能にしました。エネルギー送達システムを強化した先進的アブレーション機器の開発により、アブレーション治療の有効性と安全性が向上し、合併症のリスクが減少し、患者の転帰が改善しました。カテーテルとプローブの設計の進歩により、アブレーション技術の使いやすさと汎用性が向上し、より幅広い臨床現場での使用が可能になった。さらに、リアルタイムのモニタリングとフィードバックシステムの統合により、アブレーション手技の制御と有効性が向上しました。このような技術的進歩により、腫瘍切除技術の用途と有効性が拡大し、がん治療への導入が促進されています。

主要ユーザーとそのニーズは?

腫瘍切除技術の主要ユーザーには、腫瘍医、インターベンショナル・ラジオロジスト、外科医が含まれます。腫瘍医は、がん治療の集学的アプローチの一環として腫瘍切除術を使用し、副作用を最小限に抑えながら正確かつ効果的に腫瘍を破壊する技術を求めています。インターベンショナル・ラジオロジストは画像誘導焼灼術を行うため、正確なターゲティングとリアルタイムのモニタリングを提供する高度な画像診断および焼灼システムを必要とします。外科医は、外科的切除の補助として、あるいは外科的アクセスが困難な腫瘍の治療にアブレーション技術を利用するため、信頼性が高く汎用性の高いアブレーション装置を求めています。各ユーザーグループは、患者の転帰を改善し治療の選択肢を広げるために、高い精度、安全性、有効性を提供する腫瘍切除技術を高く評価しています。

腫瘍切除技術市場の成長の原動力は?

腫瘍切除技術市場の成長は、がん罹患率の増加、アブレーション技術の進歩、低侵襲治療に対する需要の高まりなど、いくつかの要因によってもたらされます。世界のがん罹患率の増加により、効果的で侵襲性の低い治療オプションに対するニーズが高まっており、腫瘍切除技術の採用を後押ししています。画像誘導、エネルギー送達システム、デバイス設計の改善を含むアブレーション技術の進歩は、アブレーション手技の安全性と有効性を高め、市場の成長を支えています。回復時間の短縮、合併症発生率の低下、患者の快適性の向上といった利点に後押しされた低侵襲治療への需要の高まりが、腫瘍切除技術の採用をさらに後押ししています。また、医療従事者や患者の間でアブレーション治療に対する認識や受容が高まっていることも、腫瘍切除技術市場の成長を後押ししています。

調査対象企業の例(注目の46社)

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG International Ltd.
  • EDAP TMS SA
  • Galil Medical Ltd.
  • HealthTronics, Inc.
  • Medtronic PLC
  • Mermaid Medical A/S
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15321

Global Tumor Ablation Technologies Market to Reach US$3.8 Billion by 2030

The global market for Tumor Ablation Technologies estimated at US$1.6 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2023-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Microwave Ablation segment is estimated at 14.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$429.6 Million While China is Forecast to Grow at 12.3% CAGR

The Tumor Ablation Technologies market in the U.S. is estimated at US$429.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$574.2 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Tumor Ablation Technologies Market - Key Trends & Drivers Summarized

What Are Tumor Ablation Technologies and Why Are They Crucial?

Tumor ablation technologies are minimally invasive procedures used to destroy cancerous tissues by applying extreme heat or cold, electrical energy, or chemical agents. These technologies include radiofrequency ablation (RFA), microwave ablation, cryoablation, and chemical ablation. Tumor ablation is crucial for treating localized tumors in organs such as the liver, kidney, lung, and bone, offering an alternative to traditional surgical methods. These technologies provide significant benefits, including reduced recovery time, minimal invasiveness, and the ability to target tumors with precision. Tumor ablation is particularly valuable for patients who are not candidates for surgery or those with tumors in difficult-to-reach locations.

How Have Technological Advances Shaped the Market?

Technological advances have significantly influenced the development and application of tumor ablation technologies. Innovations in imaging techniques, such as ultrasound, CT, and MRI, have improved the accuracy and guidance of ablation procedures, allowing for more precise targeting of tumors. The development of advanced ablation devices with enhanced energy delivery systems has increased the efficacy and safety of ablation treatments, reducing the risk of complications and improving patient outcomes. Advancements in catheter and probe design have improved the ease of use and versatility of ablation technologies, enabling their use in a wider range of clinical settings. Additionally, the integration of real-time monitoring and feedback systems has enhanced the control and effectiveness of ablation procedures. These technological advancements have expanded the applications and effectiveness of tumor ablation technologies, driving their adoption in cancer treatment.

Who Are the Key Users and What Are Their Needs?

The key users of tumor ablation technologies include oncologists, interventional radiologists, and surgeons. Oncologists use tumor ablation as part of a multidisciplinary approach to cancer treatment, seeking technologies that offer precise and effective tumor destruction with minimal side effects. Interventional radiologists perform image-guided ablation procedures, requiring advanced imaging and ablation systems that provide accurate targeting and real-time monitoring. Surgeons utilize ablation technologies as an adjunct to surgical resection or for treating tumors that are difficult to access surgically, demanding reliable and versatile ablation devices. Each user group values tumor ablation technologies that offer high precision, safety, and effectiveness to improve patient outcomes and expand treatment options.

What Is Driving Growth in the Tumor Ablation Technologies Market?

The growth in the tumor ablation technologies market is driven by several factors, including the increasing prevalence of cancer, advancements in ablation technologies, and the rising demand for minimally invasive treatments. The growing incidence of cancer worldwide has increased the need for effective and less invasive treatment options, driving the adoption of tumor ablation technologies. Advancements in ablation technologies, including improvements in imaging guidance, energy delivery systems, and device design, have enhanced the safety and efficacy of ablation procedures, supporting market growth. The rising demand for minimally invasive treatments, driven by the benefits of reduced recovery time, lower complication rates, and improved patient comfort, has further fueled the adoption of tumor ablation technologies. Additionally, increasing awareness and acceptance of ablation treatments among healthcare professionals and patients have supported the growth of the tumor ablation technologies market.

Select Competitors (Total 46 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG International Ltd.
  • EDAP TMS SA
  • Galil Medical Ltd.
  • HealthTronics, Inc.
  • Medtronic PLC
  • Mermaid Medical A/S
  • Misonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tumor Ablation Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cancer
    • Advancements in Imaging and Guidance Systems
    • Growth in Minimally Invasive Treatment Options
    • Impact of Technological Innovations in Ablation Devices
    • Development of Combination Therapies
    • Rising Adoption of Outpatient Procedures
    • Expansion of Radiofrequency and Microwave Ablation
    • Innovations in Cryoablation and Laser Ablation Technologies
    • Increasing Focus on Patient Safety and Treatment Efficacy
    • Growth in Clinical Research and Trials
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Tumor Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Radiofrequency Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Microwave Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Microwave Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cryoablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Tumor Ablation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Irreversible Electroporation Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Irreversible Electroporation Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Tumor Ablation Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Tumor Ablation Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Tumor Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Tumor Ablation Technologies by Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Technology - Percentage Breakdown of Value Sales for Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Tumor Ablation Technologies by Application - Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Tumor Ablation Technologies by Application - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION